Organ Transplantation Research Today is a free monthly online journal that collates and summarizes the latest research about Organ Transplantation, including details on risks, prognosis, procedure, surgery.

Volume 4 (2007), Issue 4 (April)

1. Echocardiography-based score to predict outcome after renal transplantation.
   Heart, 93(4): 464-9. [Abstract] [Full-text]
2. Dual thrombosis of the pulmonary arterial and venous anastomotic sites after single lung transplantation: role of transesophageal echocardiography in diagnosis and management.
   J Am Soc Echocardiogr, 20(4): 438.e9-12. [Abstract] [Full-text]
3. Jon Van Rood: pioneer at the crossroad of human leukocyte antigens and transplantation.
   Transfus Med Rev, 21(2): 159-63. [Abstract] [Full-text]
4. Cell specific internal translation efficiency of Epstein-Barr virus present in solid organ transplant patients.
   J Med Virol, 79(5): 573-81. [Abstract] [Full-text]
5. The alloantigenic sites of alpha3alpha4alpha5(IV) collagen: pathogenic X-linked alport alloantibodies target two accessible conformational epitopes in the alpha5NC1 domain.
   J Biol Chem, 282(14): 10670-7. [Abstract] [Full-text]
6. Detection of early renal transplant rejection by minimally-invasive monitoring of impedance variability.
   Biosens Bioelectron, 22(11): 2749-53. [Abstract] [Full-text]
7. Recipient atrial flutter masquerading as donor flutter in a heart transplant recipient.
   J Heart Lung Transplant, 26(4): 414-6. [Abstract] [Full-text]
8. Rectal and cutaneous malakoplakia in an orthotopic cardiac transplant recipient.
   J Heart Lung Transplant, 26(4): 411-3. [Abstract] [Full-text]
9. Broncholith caused by donor-acquired histoplasmosis in a lung transplant recipient.
   J Heart Lung Transplant, 26(4): 407-10. [Abstract] [Full-text]
10. Transplant vasculopathy is associated with increased AlloMap gene expression score.
    J Heart Lung Transplant, 26(4): 403-6. [Abstract] [Full-text]
11. Varicella infection after heart and lung transplantation: a single-center experience.
    J Heart Lung Transplant, 26(4): 399-402. [Abstract] [Full-text]
12. Lung transplantation in the Fischer 344-->Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans.
    J Heart Lung Transplant, 26(4): 390-8. [Abstract] [Full-text]
13. Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional sequelae in patients and spouses.
    J Heart Lung Transplant, 26(4): 384-9. [Abstract] [Full-text]
14. Sivelestat reduces reperfusion injury of lungs harvested from endotoxin-primed rats by inhibition of neutrophil-mediated inflammation.
    J Heart Lung Transplant, 26(4): 370-5. [Abstract] [Full-text]
15. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients.
    J Heart Lung Transplant, 26(4): 350-6. [Abstract] [Full-text]
16. High incidence of venous thromboembolic events in lung transplant recipients.
    J Heart Lung Transplant, 26(4): 339-44. [Abstract] [Full-text]
17. Early institution of extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation improves outcome.
    J Heart Lung Transplant, 26(4): 331-8. [Abstract] [Full-text]
18. Interplay between systemic inflammation and markers of insulin resistance in cardiovascular prognosis after heart transplantation.
    J Heart Lung Transplant, 26(4): 324-30. [Abstract] [Full-text]
19. Effect of reversible pulmonary hypertension on outcomes after heart transplantation.
    J Heart Lung Transplant, 26(4): 319-23. [Abstract] [Full-text]
20. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    J Heart Lung Transplant, 26(4): 312-8. [Abstract] [Full-text]
21. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference.
    J Heart Lung Transplant, 26(4): 305-11. [Abstract] [Full-text]
22. Positive pretransplantation cytomegalovirus serology is a risk factor for cardiac allograft vasculopathy in children.
    Circulation, 115(13): 1798-805. [Abstract] [Full-text]
23. CD40Ig treatment results in allograft acceptance mediated by CD8CD45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase.
    J Clin Invest, 117(4): 1096-106. [Abstract] [Full-text]
24. Quality of life following organ transplantation.
    Transpl Int, 20(5): 397-409. [Abstract] [Full-text]
25. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
    Expert Rev Anti Infect Ther, 5(2): 295-304. [Abstract] [Full-text]
26. Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis.
    Hepatology, 45(4): 977-81. [Abstract] [Full-text]
27. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts.
    J Clin Invest, 117(4): 989-96. [Abstract] [Full-text]
28. Short-term versus long-term induction therapy with antithymocyte globulin in orthotopic liver transplantation.
    Transpl Int, 20(5): 447-52. [Abstract] [Full-text]
29. Comparison of fluorescent polarization immunoassay (FPIA) versus HPLC to measure everolimus blood concentrations in clinical transplantation.
    Clin Chim Acta, 380(1): 217-21. [Abstract] [Full-text]
30. The implementation of a kidney exchange program does not induce a need for additional psychosocial support.
    Transpl Int, 20(5): 432-9. [Abstract] [Full-text]
31. Gene transfer of interleukin-18-binding protein attenuates cardiac allograft rejection.
    Transpl Int, 20(5): 460-6. [Abstract] [Full-text]
32. Pre-transplant risk factors predicting post-transplant cytomegalovirus infection in liver transplant recipients.
    Transpl Int, 20(5): 419-24. [Abstract] [Full-text]
33. Outcome of allogeneic vascularized knee transplants.
    Transpl Int, 20(5): 410-8. [Abstract] [Full-text]
34. Treatment of antibody-mediated rejection with high-dose immunoglobulins in ABO-incompatible liver transplant recipient.
    Transpl Int, 20(5): 467-70. [Abstract] [Full-text]
35. Cartilage thickness matching of selected donor and recipient sites for osteochondral autografting of the medial femoral condyle.
    Knee Surg Sports Traumatol Arthrosc, 15(4): 381-6. [Abstract] [Full-text]
36. An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?
    Clin Infect Dis, 44(9): 1143-9. [Abstract] [Full-text]
37. Atlantoaxial transarticular screw fixation with morselized autograft and without additional internal fixation: technical description and report of 57 cases.
    Spine, 32(6): 643-6. [Abstract] [Full-text]
38. SF-36 outcomes and fusion rates after multilevel laminectomies and 1 and 2-level instrumented posterolateral fusions using lamina autograft and demineralized bone matrix.
    J Spinal Disord Tech, 20(2): 139-45. [Abstract] [Full-text]
39. Liver transplantation: an update 2007.
    Curr Opin Gastroenterol, 23(3): 292-8. [Abstract] [Full-text]
40. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis.
    Am J Surg Pathol, 31(4): 607-14. [Abstract] [Full-text]
41. Cholesterol embolization in renal allografts: a clinicopathologic study of 12 cases.
    Am J Surg Pathol, 31(4): 536-45. [Abstract] [Full-text]
42. Free fibula donor-site morbidity: clinical and biomechanical analysis.
    Ann Plast Surg, 58(4): 405-10. [Abstract] [Full-text]
43. Cardiopulmonary bypass for lung transplantation in cystic fibrosis: pilot evaluation of perioperative outcome.
    J Cardiothorac Vasc Anesth, 21(2): 208-11. [Abstract] [Full-text]
44. Anterior cruciate ligament reconstruction using compressed bone-hamstring-bone graft.
    Arthroscopy, 23(4): 442.e1-3. [Abstract] [Full-text]
45. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
    Ther Drug Monit, 29(2): 207-14. [Abstract] [Full-text]
46. Cardiac arrest in the organ donor does not negatively influence recipient survival after heart transplantation.
    Eur J Cardiothorac Surg, 31(5): 929-33. [Abstract] [Full-text]
47. Kinetics and functional assay of liver repopulation after human cord blood transplantation.
    Dig Liver Dis, 39(5): 455-65. [Abstract] [Full-text]
48. Special considerations for patients with cystic fibrosis undergoing lung transplantation.
    Chest, 131(4): 1224-31. [Abstract] [Full-text]
49. Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients.
    Pharmacogenet Genomics, 17(5): 321-30. [Abstract] [Full-text]
50. Vascular remodeling in transplant vasculopathy.
    Circ Res, 100(7): 967-78. [Abstract] [Full-text]
51. Rapid and accurate measurement of anti-A/B IgG antibody in ABO-unmatched living donor liver transplantation by surface plasmon resonance.
    Transfus Med, 17(2): 97-106. [Abstract] [Full-text]
52. Bacterial translocation during liver transplantation: a randomized trial comparing conventional with venovenous bypass vs. piggyback methods.
    Liver Transpl, 13(4): 488-96. [Abstract] [Full-text]
53. Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation.
    Liver Transpl, 13(4): 599-606. [Abstract] [Full-text]
54. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation.
    Liver Transpl, 13(4): 579-88. [Abstract] [Full-text]
55. Induction of long-term liver allograft survival by delayed immunosuppression is dependent on interleukin-10.
    Liver Transpl, 13(4): 571-8. [Abstract] [Full-text]
56. Risk factors for invasive aspergillosis in living donor liver transplant recipients.
    Liver Transpl, 13(4): 566-70. [Abstract] [Full-text]
57. Antiinflammatory properties of IL-10 rescue small-for-size liver grafts.
    Liver Transpl, 13(4): 558-65. [Abstract] [Full-text]
58. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Liver Transpl, 13(4): 552-7. [Abstract] [Full-text]
59. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Liver Transpl, 13(4): 543-51. [Abstract] [Full-text]
60. Early posttransplantation portal vein stenosis following living donor liver transplantation: percutaneous transhepatic primary stent placement.
    Liver Transpl, 13(4): 530-6. [Abstract] [Full-text]
61. Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patients.
    Liver Transpl, 13(4): 516-22. [Abstract] [Full-text]
62. Working up donors for high-urgency and elective adult-to-adult live donor liver transplantation.
    Liver Transpl, 13(4): 509-15. [Abstract] [Full-text]
63. Liver transplantation in children with sickle-cell disease.
    Liver Transpl, 13(4): 505-8. [Abstract] [Full-text]
64. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation.
    Liver Transpl, 13(4): 497-504. [Abstract] [Full-text]
65. The use of psychosocial criteria in Australian patient selection guidelines for kidney transplantation.
    Soc Sci Med, 64(10): 2107-14. [Abstract] [Full-text]
66. Acute humoral rejection of renal transplants in alloimmunized pigs.
    J Surg Res, 139(2): 261-8. [Abstract] [Full-text]
67. A new modified technique for heterotopic femoral heart transplantation in rats.
    J Surg Res, 139(2): 157-63. [Abstract] [Full-text]
68. Urinary tract infections and bladder dysfunction after renal transplantation in children.
    J Urol, 177(5): 1883-6. [Abstract] [Full-text]
69. Computerized tomographic angiography for renal donor evaluation leads to a higher exclusion rate.
    J Urol, 177(5): 1826-9. [Abstract] [Full-text]
70. Allogenous bone grafts improved by bone marrow stem cells and platelet growth factors: clinical case reports.
    Artif Organs, 31(4): 268-73. [Abstract] [Full-text]
71. Left ventricular circulatory support as bridge to heart transplantation in Chagas' disease cardiomyopathy.
    Artif Organs, 31(4): 253-8. [Abstract] [Full-text]
72. Partial nephrectomy and autotransplantation with pyelovesicostomy for renal urothelial carcinoma in solitary kidneys: a clinical update.
    BJU Int, 99(5): 1020-3. [Abstract] [Full-text]
73. Impact of preservation solution on the extent of blood-air barrier damage and edema formation in experimental lung transplantation.
    Anat Rec (Hoboken), 290(5): 491-500. [Abstract] [Full-text]
74. Fish oil for kidney transplant recipients.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
75. Neuroimaging and neurologic complications after organ transplantation.
    J Neuroimaging, 17(2): 110-23. [Abstract] [Full-text]
76. Hyperglycemia and diabetic renal change in a model of polyvinyl alcohol bioartificial pancreas transplantation.
    Pancreas, 34(4): 458-65. [Abstract] [Full-text]
77. Percutaneous radiofrequency ablation of tumor in transplanted kidney.
    Urology, 69(4): 778.e5-7. [Abstract] [Full-text]
78. Deceased-donor kidney transplantation in prune belly syndrome.
    Urology, 69(4): 666-9. [Abstract] [Full-text]
79. Necessity of routine postoperative heparinization in non-risky live-donor renal transplantation: results of a prospective randomized trial.
    Urology, 69(4): 647-51. [Abstract] [Full-text]
80. Chronic rejection: an enduring enigma of transplantation biology.
    Transplant Proc, 39(3): 773-8. [Abstract] [Full-text]
81. Polyclonal antibodies in renal transplantation--a relook.
    Transplant Proc, 39(3): 766-72. [Abstract] [Full-text]
82. Transplant arteriopathy.
    Transplant Proc, 39(3): 763-5. [Abstract] [Full-text]
83. Management of calculi in a donor kidney.
    Transplant Proc, 39(3): 761-2. [Abstract] [Full-text]
84. Monitoring of anti-HLA and anti-Major histocompatibility complex class I related chain A antibodies in living related renal donor transplantation.
    Transplant Proc, 39(3): 759-60. [Abstract] [Full-text]
85. Challenge of tuberculosis in renal transplantation.
    Transplant Proc, 39(3): 756-8. [Abstract] [Full-text]
86. Growth in pediatric renal transplant recipients.
    Transplant Proc, 39(3): 753-5. [Abstract] [Full-text]
87. Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry.
    Transplant Proc, 39(3): 750-2. [Abstract] [Full-text]
88. Tacrolimus (Pan Graf) in live related renal transplantation: an initial experience of 101 recipients in India.
    Transplant Proc, 39(3): 747-9. [Abstract] [Full-text]
89. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
    Transplant Proc, 39(3): 744-6. [Abstract] [Full-text]
90. Focal segmental glomerulosclerosis and renal transplantation.
    Transplant Proc, 39(3): 737-43. [Abstract] [Full-text]
91. Recurrent glomerulopathy in the renal allograft.
    Transplant Proc, 39(3): 734-6. [Abstract] [Full-text]
92. Opportunistic infections in renal allograft recipients.
    Transplant Proc, 39(3): 731-3. [Abstract] [Full-text]
93. Transplantation from non-heart-beating donors.
    Transplant Proc, 39(3): 726-7. [Abstract] [Full-text]
94. Impact of retroperitoneoscopic donor nephrectomy on renal allograft in Indian and African recipients.
    Transplant Proc, 39(3): 723-5. [Abstract] [Full-text]
95. Cadaveric renal transplantation: our experience at the Institute of Kidney Diseases & Research Centre, Institute of Transplantation Sciences, Ahmedabad.
    Transplant Proc, 39(3): 721-2. [Abstract] [Full-text]
96. Organ donation and transplantation-the Chennai experience in India.
    Transplant Proc, 39(3): 714-8. [Abstract] [Full-text]
97. Indian Transplant Registry-www.transplantindia.com.
    Transplant Proc, 39(3): 711-3. [Abstract] [Full-text]
98. Transplant rejection under the microscope.
    Transplant Proc, 39(3): 662-6. [Abstract] [Full-text]
99. First case of simultaneous heart plus kidney transplantation in Chile: case report.
    Transplant Proc, 39(3): 625-6. [Abstract] [Full-text]
100. Cytomegalovirus infections in cardiac transplant patients: an experience at a clinical hospital, university of Chile.
     Transplant Proc, 39(3): 622-4. [Abstract] [Full-text]
101. Heart transplantation in chile: preliminary report from the Gustavo Fricke hospital in Vina del Mar.
     Transplant Proc, 39(3): 619-21. [Abstract] [Full-text]
102. Family interactions of liver transplanted children: are they normal?
     Transplant Proc, 39(3): 615-6. [Abstract] [Full-text]
103. Oral ulcers produced by mycophenolate mofetil in two liver transplant patients.
     Transplant Proc, 39(3): 612-4. [Abstract] [Full-text]
104. Pediatric liver retransplantation: indications and outcome.
     Transplant Proc, 39(3): 609-11. [Abstract] [Full-text]
105. Converting to a generic formulation of mycophenolate mofetil in stable kidney transplant recipients: 1 year of drug surveillance and outcome.
     Transplant Proc, 39(3): 602-5. [Abstract] [Full-text]
106. Report of the experience with enteric-coated sodium mycophenolate in a de novo population of kidney transplant recipients at high risk for delayed graft function.
     Transplant Proc, 39(3): 600-1. [Abstract] [Full-text]
107. Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy.
     Transplant Proc, 39(3): 596-9. [Abstract] [Full-text]
108. Case report of a kidney transplant recipient converted to everolimus due to malignancy: resolution of bronchiolitis obliterans organizing pneumonia without everolimus discontinuation.
     Transplant Proc, 39(3): 594-5. [Abstract] [Full-text]
109. Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria.
     Transplant Proc, 39(3): 591-3. [Abstract] [Full-text]
110. 14th International HLA and Immunogenetics Workshop: report on the structural basis of HLA compatibility.
     Tissue Antigens, 69: 180-4. [Abstract] [Full-text]
111. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
     Tissue Antigens, 69: 174-9. [Abstract] [Full-text]
112. 14th International HLA and Immunogenetics Workshop: report on understanding antibodies in transplantation.
     Tissue Antigens, 69: 160-73. [Abstract] [Full-text]
113. Laboratory diagnosis and nonoperative management of biliary complications in living donor liver transplant patients.
     J Clin Gastroenterol, 41(5): 501-6. [Abstract] [Full-text]
114. Diabetic myonecrosis in an orthotopic heart transplant recipient.
     J Heart Lung Transplant, 26(5): 549-52. [Abstract] [Full-text]
115. Getting old with a new heart: impact of age on depression and quality of life in long-term heart transplant recipients.
     J Heart Lung Transplant, 26(5): 544-8. [Abstract] [Full-text]
116. Patterns and predictors of quality of life at 5 to 10 years after heart transplantation.
     J Heart Lung Transplant, 26(5): 535-43. [Abstract] [Full-text]
117. Results of clinical lung transplant from uncontrolled non-heart-beating donors.
     J Heart Lung Transplant, 26(5): 529-34. [Abstract] [Full-text]
118. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
     J Heart Lung Transplant, 26(5): 516-21. [Abstract] [Full-text]
119. Successful management of antibody-mediated cardiac allograft rejection with combined immunoadsorption and anti-CD20 monoclonal antibody treatment: case report and literature review.
     J Heart Lung Transplant, 26(5): 511-5. [Abstract] [Full-text]
120. A randomized, controlled trial of daclizumab vs anti-thymocyte globulin induction for lung transplantation.
     J Heart Lung Transplant, 26(5): 504-10. [Abstract] [Full-text]
121. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
     J Heart Lung Transplant, 26(5): 498-503. [Abstract] [Full-text]
122. Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern.
     J Heart Lung Transplant, 26(5): 494-7. [Abstract] [Full-text]
123. Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
     J Heart Lung Transplant, 26(5): 485-93. [Abstract] [Full-text]
124. Analysis of cardiac dimensions, mass and function in heart transplant recipients using 64-slice multi-detector computed tomography.
     J Heart Lung Transplant, 26(5): 478-84. [Abstract] [Full-text]
125. Extracorporeal membrane oxygenation for primary graft dysfunction after lung transplantation: analysis of the Extracorporeal Life Support Organization (ELSO) registry.
     J Heart Lung Transplant, 26(5): 472-7. [Abstract] [Full-text]
126. Outcomes after lung transplantation in patients with chronic hepatitis C virus infection.
     J Heart Lung Transplant, 26(5): 466-71. [Abstract] [Full-text]
127. Pre-transplant risk factors for chronic renal dysfunction after pediatric heart transplantation: a 10-year national cohort study.
     J Heart Lung Transplant, 26(5): 458-65. [Abstract] [Full-text]
128. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
     J Heart Lung Transplant, 26(5): 447-52. [Abstract] [Full-text]
129. Potential refinements of the International Society for Heart and Lung Transplantation primary graft dysfunction grading system.
     J Heart Lung Transplant, 26(5): 431-6. [Abstract] [Full-text]
130. Surgical induction of temporomandibular joint ankylosis: an animal model.
     J Oral Maxillofac Surg, 65(5): 993-1004. [Abstract] [Full-text]
131. Immediate reconstruction of mandibular defects: a retrospective report of 242 cases.
     J Oral Maxillofac Surg, 65(5): 883-90. [Abstract] [Full-text]
132. Biological assessment of porous-implant hydroxyapatite combined with periosteal grafting in maxillary defects.
     J Oral Maxillofac Surg, 65(5): 847-54. [Abstract] [Full-text]
133. Influence of rabeprazole and lansoprazole on the pharmacokinetics of tacrolimus in relation to CYP2C19, CYP3A5 and MDR1 polymorphisms in renal transplant recipients.
     Biopharm Drug Dispos, 28(4): 167-75. [Abstract] [Full-text]
134. Cold heparinized lactated Ringers with procaine (HeLP) preservation fluid in 266 living donor kidney transplantations.
     Transplantation, 83(8): 1134-6. [Abstract] [Full-text]
135. Blood concentration curve of cyclosporine: impact of itraconazole in lung transplant recipients.
     Transplantation, 83(8): 1130-3. [Abstract] [Full-text]
136. Antibodies against glutathione S-transferase T1 (GSTT1) in patients with GSTT1 null genotype as prognostic marker: long-term follow-up after liver transplantation.
     Transplantation, 83(8): 1126-9. [Abstract] [Full-text]
137. Experimental and clinical significance of antinuclear antibodies in liver transplantation.
     Transplantation, 83(8): 1122-5. [Abstract] [Full-text]
138. Pitavastatin suppresses acute and chronic rejection in murine cardiac allografts.
     Transplantation, 83(8): 1093-7. [Abstract] [Full-text]
139. Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients.
     Transplantation, 83(8): 1069-74. [Abstract] [Full-text]
140. The functional, metabolic, and anabolic responses to exercise training in renal transplant and hemodialysis patients.
     Transplantation, 83(8): 1059-68. [Abstract] [Full-text]
141. No association of factor V Leiden, prothrombin G20210A, and MTHFR C677T gene polymorphisms with kidney allograft survival: a multicenter study.
     Transplantation, 83(8): 1055-8. [Abstract] [Full-text]
142. Gene-expression profiles and age of donor kidney biopsies obtained before transplantation distinguish medium term graft function.
     Transplantation, 83(8): 1048-54. [Abstract] [Full-text]
143. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk.
     Transplantation, 83(8): 1041-7. [Abstract] [Full-text]
144. Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection.
     Transplantation, 83(8): 1035-40. [Abstract] [Full-text]
145. Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients.
     Transplantation, 83(8): 1027-34. [Abstract] [Full-text]
146. Combined bone allograft and adipose-derived stem cell autograft in a rabbit model.
     Ann Plast Surg, 58(5): 561-5. [Abstract] [Full-text]
147. Renal pathology in the pediatric transplant patient.
     Adv Anat Pathol, 14(3): 202-16. [Abstract] [Full-text]
148. Intrasubject medication adherence patterns.
     Clin Nurs Res, 16(2): 153-63. [Abstract] [Full-text]
149. Intraoperative blood salvage during liver resection: a randomized controlled trial.
     Ann Surg, 245(5): 686-91. [Abstract] [Full-text]
150. Malignancies in renal transplantation: an unmet medical need.
     Nephrol Dial Transplant, 22: i4-10. [Abstract] [Full-text]
151. Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
     Nephrol Dial Transplant, 22: i36-41. [Abstract] [Full-text]
152. Post-transplant lymphoproliferative disorder--the potential of proliferation signal inhibitors.
     Nephrol Dial Transplant, 22: i27-35. [Abstract] [Full-text]
153. Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation.
     Nephrol Dial Transplant, 22: i23-6. [Abstract] [Full-text]
154. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
     Nephrol Dial Transplant, 22: i17-22. [Abstract] [Full-text]
155. The radiologist's role in managing paediatric liver transplantation: personal experience with 40 patients.
     Radiol Med (Torino), 112(3): 456-71. [Abstract] [Full-text]
156. The role of proliferation signal inhibitors in post-transplant malignancies.
     Nephrol Dial Transplant, 22: i11-6. [Abstract] [Full-text]
157. Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection.
     Semin Respir Crit Care Med, 28(2): 222-42. [Abstract] [Full-text]
158. Complications after a 5-year experience with laparoscopic donor nephrectomy: the Indiana University experience.
     Surg Endosc, 21(5): 724-8. [Abstract] [Full-text]
159. Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients.
     Pediatr Nephrol, 22(5): 734-41. [Abstract] [Full-text]
160. Diagnosis of de novo localized thrombotic microangiopathy by surveillance biopsy.
     Pediatr Nephrol, 22(5): 742-6. [Abstract] [Full-text]
161. Bone regeneration 6 years after impaction bone grafting: a PET analysis.
     Acta Orthop, 78(2): 201-5. [Abstract] [Full-text]
162. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
     Hum Immunol, 68(5): 362-7. [Abstract] [Full-text]
163. A novel technique for heterotopic vascularized pancreas transplantation in mice to assess ischemia reperfusion injury and graft pancreatitis.
     Surgery, 141(5): 682-9. [Abstract] [Full-text]
164. A revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor transplantation in hepatocellular carcinoma.
     Surgery, 141(5): 598-609. [Abstract] [Full-text]
165. Graft pneumonectomy and delayed contralateral lung transplantation.
     Ann Thorac Surg, 83(5): 1891-3. [Abstract] [Full-text]
166. Geometric disproportion of cardiac structure and graft ischemia affect tricuspid valve regurgitation early after neonatal heart transplantation.
     Ann Thorac Surg, 83(5): 1774-80. [Abstract] [Full-text]
167. Orthotopic heart transplantation in patients with Marfan syndrome.
     Ann Thorac Surg, 83(5): 1691-5. [Abstract] [Full-text]
168. Significance of neurologic complications in the modern era of cardiac transplantation.
     Ann Thorac Surg, 83(5): 1684-90. [Abstract] [Full-text]
169. Outcomes of invasive zygomycosis infections in renal transplant recipients.
     Transpl Infect Dis, 9(2): 161-4. [Abstract] [Full-text]
170. Coccidioidomycosis masked by symptoms of end-stage liver disease in transplant candidates.
     Transpl Infect Dis, 9(2): 153-5. [Abstract] [Full-text]
171. The onset of rapidly progressive neurologic deterioration after a brief gastrointestinal illness in a renal allograft recipient.
     Transpl Infect Dis, 9(2): 142-7. [Abstract] [Full-text]
172. Donor-transmitted toxoplasmosis in liver transplant recipients: a case report and literature review.
     Transpl Infect Dis, 9(2): 132-6. [Abstract] [Full-text]
173. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study.
     Transpl Infect Dis, 9(2): 121-5. [Abstract] [Full-text]
174. Infections associated with ventricular assist devices: epidemiology and effect on prognosis after transplantation.
     Transpl Infect Dis, 9(2): 114-20. [Abstract] [Full-text]
175. Tuberculosis in renal transplant recipients.
     Transpl Infect Dis, 9(2): 97-101. [Abstract] [Full-text]
176. New treatments for acute humoral rejection of kidney allografts.
     Expert Opin Investig Drugs, 16(5): 625-33. [Abstract] [Full-text]
177. Metabolic follow-up after long-term pancreas graft survival.
     Eur J Endocrinol, 156(5): 603-10. [Abstract] [Full-text]
178. Advances in lung transplantation for patients who have cystic fibrosis.
     Clin Chest Med, 28(2): 445-57. [Abstract] [Full-text]
179. Life-supporting function of genetically modified swine lungs in baboons.
     J Thorac Cardiovasc Surg, 133(5): 1354-63. [Abstract] [Full-text]
180. Perioperative outcomes of cardiac surgery in kidney and kidney-pancreas transplant recipients.
     J Thorac Cardiovasc Surg, 133(5): 1212-9. [Abstract] [Full-text]
181. Fresh-frozen osteochondral allograft reconstruction of a giant cell tumor of the talus.
     J Foot Ankle Surg, 46(3): 144-8. [Abstract] [Full-text]

© 2004-2011 Organ Transplantation Research Today. All Rights Reserved.